Paul Hudson is leading the execution of Sanofi’s Play to Win strategy, a six-year plan (2020-2025) designed with the ambition to leverage breakthrough science to change the practice of medicine and to foster a workplace where people can bring their best selves to work. The strategy has sharpened the focus on key R&D areas, including immunology, vaccines, hemophilia, oncology, and rare diseases, with the objective of delivering breakthrough solutions to patients and improve people’s health worldwide. Under Paul’s leadership, and in the middle of a global pandemic, Sanofi has renewed its commitments to society, putting sustainability and social responsibility at the core of its long-term strategy. Before joining Sanofi, Paul was CEO of Novartis Pharmaceuticals from 2016 to 2019, and a member of the Novartis Executive Committee. His career in healthcare has spanned the globe, with assignments in the US, Japan and Europe. Paul holds a degree in economics from Manchester Metropolitan University in the UK.